Genopathy
Gene-Disorder Association · Article
Gene
MITF
Melanocyte Inducing Transcription Factor
Disorder
Melanoma
Manually curatedApproved treatment annotated
Association Review

In brief

The association between MITF (Melanocyte Inducing Transcription Factor) and Melanoma is a manually-curated gene–disease association, supported by 2 contributing sources, 1 of them expert-curated.

Sources 2
Clinical variants 1
Symptoms 2
Compounds 2
Trials 160of 296 via MITF compounds
Publications 98
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
MITF

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Melanoma

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

1 clinical variant

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Population genetics

GWAS signals

2 GWAS phenotypes

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
07
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
08
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
09
Human studies

Clinical trials

296 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
10
Literature

Reading

98 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
11
Provenance

References & sources

18 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access